Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.

Alhallak K, Rebello LG, Muldoon TJ, Quinn KP, Rajaram N.

Biomed Opt Express. 2016 Oct 3;7(11):4364-4374.

2.

Identification of targets of miRNA-221 and miRNA-222 in fulvestrant-resistant breast cancer.

Liu P, Sun M, Jiang W, Zhao J, Liang C, Zhang H.

Oncol Lett. 2016 Nov;12(5):3882-3888.

3.

Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma.

Li Y, Huang R, Li X, Li X, Yu D, Zhang M, Wen J, Goscinski MA, Trope CG, Nesland JM, Suo Z.

Am J Cancer Res. 2016 Sep 1;6(9):2076-2087.

4.

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.

Xu X, Zhang Y, Jasper J, Lykken E, Alexander PB, Markowitz GJ, McDonnell DP, Li QJ, Wang XF.

Oncotarget. 2016 Apr 12;7(15):20381-94. doi: 10.18632/oncotarget.7953.

5.

MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression.

Lu W, Ning H, Gu L, Peng H, Wang Q, Hou R, Fu M, Hoft DF, Liu J.

Cancer Res. 2016 Mar 15;76(6):1429-40. doi: 10.1158/0008-5472.CAN-15-1115.

PMID:
26833120
6.

Oxidative stress inhibits distant metastasis by human melanoma cells.

Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ.

Nature. 2015 Nov 12;527(7577):186-91. doi: 10.1038/nature15726.

7.

Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.

Simões RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, Sukenick G, Locasale JW, Blasberg RG, Koutcher JA, Ackerstaff E.

Neoplasia. 2015 Aug;17(8):671-84. doi: 10.1016/j.neo.2015.08.005.

8.
9.

Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells.

Phannasil P, Thuwajit C, Warnnissorn M, Wallace JC, MacDonald MJ, Jitrapakdee S.

PLoS One. 2015 Jun 12;10(6):e0129848. doi: 10.1371/journal.pone.0129848.

10.

OVCAR-3 spheroid-derived cells display distinct metabolic profiles.

Vermeersch KA, Wang L, Mezencev R, McDonald JF, Styczynski MP.

PLoS One. 2015 Feb 17;10(2):e0118262. doi: 10.1371/journal.pone.0118262.

11.

Non-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.

Rajaram N, Reesor AF, Mulvey CS, Frees AE, Ramanujam N.

PLoS One. 2015 Jan 30;10(1):e0117132. doi: 10.1371/journal.pone.0117132.

12.

Distinct metabolic responses of an ovarian cancer stem cell line.

Vermeersch KA, Wang L, McDonald JF, Styczynski MP.

BMC Syst Biol. 2014 Dec 18;8:134. doi: 10.1186/s12918-014-0134-y.

13.

The pentose phosphate pathway and cancer.

Patra KC, Hay N.

Trends Biochem Sci. 2014 Aug;39(8):347-54. doi: 10.1016/j.tibs.2014.06.005. Review.

14.

Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis.

Saha A, Connelly S, Jiang J, Zhuang S, Amador DT, Phan T, Pilz RB, Boss GR.

Mol Cell. 2014 Jul 17;55(2):264-76. doi: 10.1016/j.molcel.2014.05.028.

15.

Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.

Rajaram N, Frees AE, Fontanella AN, Zhong J, Hansen K, Dewhirst MW, Ramanujam N.

PLoS One. 2013 Oct 18;8(10):e76524. doi: 10.1371/journal.pone.0076524.

16.

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

Semenza GL.

J Clin Invest. 2013 Sep;123(9):3664-71. doi: 10.1172/JCI67230. Review.

17.

Applications of metabolomics in cancer research.

Vermeersch KA, Styczynski MP.

J Carcinog. 2013 Jun 18;12:9. doi: 10.4103/1477-3163.113622.

18.

MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity.

Barupal DK, Haldiya PK, Wohlgemuth G, Kind T, Kothari SL, Pinkerton KE, Fiehn O.

BMC Bioinformatics. 2012 May 16;13:99.

19.

Selection of metastatic breast cancer cells based on adaptability of their metabolic state.

Singh B, Tai K, Madan S, Raythatha MR, Cady AM, Braunlin M, Irving LR, Bajaj A, Lucci A.

PLoS One. 2012;7(5):e36510. doi: 10.1371/journal.pone.0036510.

20.

Ribose 5-phosphate glycation reduces cytochrome c respiratory activity and membrane affinity.

Hildick-Smith GJ, Downey MC, Gretebeck LM, Gersten RA, Sandwick RK.

Biochemistry. 2011 Dec 27;50(51):11047-57. doi: 10.1021/bi2012977.

Items per page

Supplemental Content

Support Center